Preclinical safety assessment of Angelica acutiloba using a 13-week repeated dose oral toxicity study in rats

Abstract Angelica acutiloba (AA), a Japanese species of Danggui, has been used worldwide as a traditional herbal medicine with several bioactivities including anti-diabetic, anti-allergic, anti-inflammatory, anti-tumor, and anti-obesity. However, there is lack of toxicological data available to eval...

Full description

Bibliographic Details
Main Authors: Jun-Won Yun, Euna Kwon, Seung-Hyun Kim, Ji-Ran You, Yun-Soon Kim, In Ae Park, Hyeon Hoe Kim, Jeong-Hwan Che, Byeong-Cheol Kang
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Laboratory Animal Research
Subjects:
Online Access:http://link.springer.com/article/10.5625/lar.2017.33.3.223
id doaj-73069e1151cc44f1b2f58b045d6d2a80
record_format Article
spelling doaj-73069e1151cc44f1b2f58b045d6d2a802020-11-25T03:08:48ZengBMCLaboratory Animal Research2233-76602017-12-0133322323010.5625/lar.2017.33.3.223Preclinical safety assessment of Angelica acutiloba using a 13-week repeated dose oral toxicity study in ratsJun-Won Yun0Euna Kwon1Seung-Hyun Kim2Ji-Ran You3Yun-Soon Kim4In Ae Park5Hyeon Hoe Kim6Jeong-Hwan Che7Byeong-Cheol Kang8Department of Biotechnology, The Catholic University of KoreaDepartment of Experimental Animal Research, Biomedical Research Institute, Seoul National University HospitalDepartment of Experimental Animal Research, Biomedical Research Institute, Seoul National University HospitalDepartment of Experimental Animal Research, Biomedical Research Institute, Seoul National University HospitalDepartment of Experimental Animal Research, Biomedical Research Institute, Seoul National University HospitalDepartment of Pathology, Seoul National University College of MedicineDepartment of Urology, Seoul National University College of MedicineBiomedical Center for Animal Resource and Development, Seoul National University College of MedicineDepartment of Experimental Animal Research, Biomedical Research Institute, Seoul National University HospitalAbstract Angelica acutiloba (AA), a Japanese species of Danggui, has been used worldwide as a traditional herbal medicine with several bioactivities including anti-diabetic, anti-allergic, anti-inflammatory, anti-tumor, and anti-obesity. However, there is lack of toxicological data available to evaluate potential long-term toxicity and the no-observed-adverse-effect level (NOAEL) of AA extract in accordance with the test guidelines published by the Organization for Economic Cooperation and Development. In the 14-day repeat-dose toxicity study, no adverse effects on mortality, body weight change, clinical signs, and organ weights was found following repeat oral administration to rats for 14 days (125, 250, 500, 1000, and 2000 mg/kg body weight), leading that 2000 mg/kg is the highest recommended dose of AA extract for the 13-week repeat-dose oral toxicity study. In the 13-week repeat-dose oral toxicity study, the AA extract was orally administered to groups of rats for 13 weeks (125, 250, 500, 1000, and 2000 mg/kg body weight) to compare between control and AA extract groups. The administration of AA extract did not produce mortality or remarkable clinical signs during this 13-week study. And, the data revealed that there were no significant differences in food/water consumption, body weight, hematological parameters, clinical chemistry parameters, gross macroscopic findings, organ weight and histopathology in comparison to the control group. On the basis of these results, the subchronic NOAEL of the AA extract was more than 2000 mg/kg/day when tested in rats. And, the AA extract is considered safe to use orally as a traditional herbal medicine.http://link.springer.com/article/10.5625/lar.2017.33.3.223Angelica acutilobatraditional medicinetoxicitysubchronic
collection DOAJ
language English
format Article
sources DOAJ
author Jun-Won Yun
Euna Kwon
Seung-Hyun Kim
Ji-Ran You
Yun-Soon Kim
In Ae Park
Hyeon Hoe Kim
Jeong-Hwan Che
Byeong-Cheol Kang
spellingShingle Jun-Won Yun
Euna Kwon
Seung-Hyun Kim
Ji-Ran You
Yun-Soon Kim
In Ae Park
Hyeon Hoe Kim
Jeong-Hwan Che
Byeong-Cheol Kang
Preclinical safety assessment of Angelica acutiloba using a 13-week repeated dose oral toxicity study in rats
Laboratory Animal Research
Angelica acutiloba
traditional medicine
toxicity
subchronic
author_facet Jun-Won Yun
Euna Kwon
Seung-Hyun Kim
Ji-Ran You
Yun-Soon Kim
In Ae Park
Hyeon Hoe Kim
Jeong-Hwan Che
Byeong-Cheol Kang
author_sort Jun-Won Yun
title Preclinical safety assessment of Angelica acutiloba using a 13-week repeated dose oral toxicity study in rats
title_short Preclinical safety assessment of Angelica acutiloba using a 13-week repeated dose oral toxicity study in rats
title_full Preclinical safety assessment of Angelica acutiloba using a 13-week repeated dose oral toxicity study in rats
title_fullStr Preclinical safety assessment of Angelica acutiloba using a 13-week repeated dose oral toxicity study in rats
title_full_unstemmed Preclinical safety assessment of Angelica acutiloba using a 13-week repeated dose oral toxicity study in rats
title_sort preclinical safety assessment of angelica acutiloba using a 13-week repeated dose oral toxicity study in rats
publisher BMC
series Laboratory Animal Research
issn 2233-7660
publishDate 2017-12-01
description Abstract Angelica acutiloba (AA), a Japanese species of Danggui, has been used worldwide as a traditional herbal medicine with several bioactivities including anti-diabetic, anti-allergic, anti-inflammatory, anti-tumor, and anti-obesity. However, there is lack of toxicological data available to evaluate potential long-term toxicity and the no-observed-adverse-effect level (NOAEL) of AA extract in accordance with the test guidelines published by the Organization for Economic Cooperation and Development. In the 14-day repeat-dose toxicity study, no adverse effects on mortality, body weight change, clinical signs, and organ weights was found following repeat oral administration to rats for 14 days (125, 250, 500, 1000, and 2000 mg/kg body weight), leading that 2000 mg/kg is the highest recommended dose of AA extract for the 13-week repeat-dose oral toxicity study. In the 13-week repeat-dose oral toxicity study, the AA extract was orally administered to groups of rats for 13 weeks (125, 250, 500, 1000, and 2000 mg/kg body weight) to compare between control and AA extract groups. The administration of AA extract did not produce mortality or remarkable clinical signs during this 13-week study. And, the data revealed that there were no significant differences in food/water consumption, body weight, hematological parameters, clinical chemistry parameters, gross macroscopic findings, organ weight and histopathology in comparison to the control group. On the basis of these results, the subchronic NOAEL of the AA extract was more than 2000 mg/kg/day when tested in rats. And, the AA extract is considered safe to use orally as a traditional herbal medicine.
topic Angelica acutiloba
traditional medicine
toxicity
subchronic
url http://link.springer.com/article/10.5625/lar.2017.33.3.223
work_keys_str_mv AT junwonyun preclinicalsafetyassessmentofangelicaacutilobausinga13weekrepeateddoseoraltoxicitystudyinrats
AT eunakwon preclinicalsafetyassessmentofangelicaacutilobausinga13weekrepeateddoseoraltoxicitystudyinrats
AT seunghyunkim preclinicalsafetyassessmentofangelicaacutilobausinga13weekrepeateddoseoraltoxicitystudyinrats
AT jiranyou preclinicalsafetyassessmentofangelicaacutilobausinga13weekrepeateddoseoraltoxicitystudyinrats
AT yunsoonkim preclinicalsafetyassessmentofangelicaacutilobausinga13weekrepeateddoseoraltoxicitystudyinrats
AT inaepark preclinicalsafetyassessmentofangelicaacutilobausinga13weekrepeateddoseoraltoxicitystudyinrats
AT hyeonhoekim preclinicalsafetyassessmentofangelicaacutilobausinga13weekrepeateddoseoraltoxicitystudyinrats
AT jeonghwanche preclinicalsafetyassessmentofangelicaacutilobausinga13weekrepeateddoseoraltoxicitystudyinrats
AT byeongcheolkang preclinicalsafetyassessmentofangelicaacutilobausinga13weekrepeateddoseoraltoxicitystudyinrats
_version_ 1724664019103514624